Hydrochlorothiazide (HCTZ)
Sponsors
Novartis, GlaxoSmithKline, Merck Sharp & Dohme LLC, University of Maryland, Baltimore, Organon and Co
Conditions
Cardiovascular EventsDiabetes MellitusDiabetes Mellitus, Type 2Endocrine System DiseasesEssential HypertensionGlucose Metabolism DisordersHealthyHypertension
Phase 1
A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or Hydrochlorothiazide
CompletedNCT00671424
Start: 2008-03-31End: 2008-05-31Target: 48Updated: 2012-03-19
Multiple Dose Effects of Hydrochlorothiazide and Isosorbide Mononitrate on Glucose Homeostasis (MK-0000-117)(Completed)
CompletedNCT00871871
Start: 2009-03-31End: 2010-03-31Updated: 2015-07-28
Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)
CompletedNCT00953680
Start: 2004-04-30End: 2004-07-31Updated: 2022-02-09
Aldosterone and the Metabolic Syndrome
CompletedNCT01103245
Start: 2010-03-31End: 2013-09-30Updated: 2018-11-05
A Study of MK-7145 Compared to Placebo and Hydrochlorothiazide for Lowering Blood Pressure in Male Participants With Hypertension (MK-7145-009)
CompletedNCT01370655
Start: 2011-06-15End: 2012-01-26Updated: 2018-09-21
Influence of Food on the Bioavailability of Two Doses of Telmisartan/HCTZ Fixed-dose Combination in Japanese Healthy Male Volunteers
CompletedNCT02276378
Start: 2008-07-31Updated: 2014-10-28
Phase 2
A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension
CompletedNCT01256411
Start: 2010-11-30End: 2012-04-30Updated: 2015-10-21
To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy
TerminatedNCT01302899
Start: 2011-01-31End: 2011-12-31Updated: 2013-01-30
Phase 3
A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.
CompletedNCT00386607
Start: 2006-10-31End: 2008-07-31Updated: 2014-02-10
Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension
CompletedNCT00765674
Start: 2008-09-30End: 2009-08-31Updated: 2011-05-09
A Study to Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension (0954-021)(COMPLETED)
CompletedNCT00886600
Start: 1991-05-31End: 1992-08-31Updated: 2015-08-27
A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People
TerminatedNCT01259297
Start: 2011-01-31End: 2012-11-30Updated: 2014-04-08
Diuretic Comparison Project
CompletedNCT02185417
Start: 2016-06-15End: 2022-12-29Updated: 2024-05-22
Phase 4
Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus
CompletedNCT00787605
Start: 2008-11-30End: 2010-01-31Updated: 2016-10-27
Salt Loading and Thiazide Intervention Study
CompletedNCT00896389
Start: 2009-10-31End: 2013-03-31Updated: 2022-03-25
ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling
CompletedNCT01176032
Start: 2010-06-30End: 2013-04-30Updated: 2014-07-24